00:00What if AI could cut drug discovery time from years to just months?
00:04What if the cure for diseases we thought were untouchable is locked inside a data pattern,
00:08one that only an algorithm can see?
00:10That isn't a what-if anymore.
00:12It's happening right now.
00:14We're in the middle of a revolution in medicine,
00:16and it's being powered by artificial intelligence.
00:18For decades, the pharmaceutical industry has followed the same playbook.
00:21But today, AI is rewriting the rules.
00:24It's sifting through billions of data points,
00:26predicting how molecules will behave,
00:27and identifying new drug targets at a speed that was once science fiction.
00:31This isn't just a minor upgrade.
00:33It's a fundamental shift in how we create life-saving medicines.
00:36To understand why this is such a big deal,
00:38you need to know what the old way looks like.
00:40Traditionally, discovering one new, successful drug is a brutal process.
00:44It takes 10 to 15 years on average.
00:46It starts with identifying a possible target in the body,
00:49then screening thousands, sometimes millions of chemical compounds to find a hit.
00:53Most of these fail.
00:54In fact, 90% of drugs that look promising in the lab fail once they get to human clinical trials.
01:00This staggering failure rate is why the average cost to bring just one new drug to your pharmacy
01:04is estimated to be over $2.5 billion.
01:07It's slow, it's expensive, and it's incredibly risky.
01:11But AI is flipping this model on its head.
01:13It's not just making the old process faster.
01:16It's creating entirely new ones.
01:18Take InSilico Medicine.
01:19They use their generative AI platform to discover and design a new drug for idiopathic pulmonary fibrosis,
01:25a terrible lung disease.
01:26The entire process, from initial target discovery to the start of clinical trials,
01:31took less than 30 months.
01:32That's a fraction of the traditional time.
01:34It's also about precision.
01:36Scientists are now using AI to tackle targets once considered undruggable.
01:40These are proteins involved in diseases like cancer that are notoriously difficult to design a drug for.
01:45By modeling proteins in 3D and running billions of simulations,
01:49AI can find tiny hidden pockets on these targets,
01:52leading to brand new classes of inhibitors for cancers,
01:54like those driven by the KRAS gene.
01:57We're even seeing it in real-world applications.
01:59Bristol-Myers Squibb recently stated that 100% of their small-molecule drug programs
02:03now start with AI-predicted experiments.
02:06AI is no longer a side project.
02:08It's central to the entire R&D pipeline.
02:10The potential benefits are obvious.
02:12Faster cures, lower development costs, which could mean cheaper drugs,
02:16and highly personalized treatments designed for your unique genetic makeup.
02:20But this new power also comes with massive challenges.
02:22First, data quality.
02:24AI is only as good as the data it's trained on.
02:27If our biological and clinical data has hidden biases,
02:30for example, if it's not diverse enough,
02:32the AI could create drugs that work for one group of people but not others.
02:35Second, the black box problem.
02:38Some complex AI models can find a pattern and suggest a new drug,
02:41but even the creators don't know exactly why the AI made that choice.
02:45This is a huge hurdle for regulators like the FDA,
02:48who need to know precisely how a drug works, and why it's safe.
02:51And finally there's the validation gap.
02:54An AI can be a genius in a simulation,
02:56but the human body is infinitely more complex.
02:58We still have to prove that what works on a computer
03:00will work safely and effectively in a person.
03:03The experts on the front lines see both the promise and the peril.
03:07As one advisor at a recent FDA workshop put it,
03:09we don't just want a faster horse.
03:11We need to build the car.
03:13This isn't about small improvements.
03:15It's about reinventing the vehicle.
03:17The head of drug R&D at Merck estimates their AI collaborations
03:20could accelerate discovery timelines by 50 to 60%.
03:23But perhaps the most powerful quote from that FDA meeting was this,
03:27the risk isn't in using AI, it's in not using it soon enough.
03:30AI is fundamentally changing the equation for human health.
03:33It's compressing a decade of work into a few years, or even months.
03:36It's finding answers in complexity that our brains could never find alone.
03:41The challenges of data regulation and ethics are real and difficult.
03:44But the potential to alleviate suffering, to cure the incurable,
03:48and to create a new era of medicine is no longer a distant dream.
03:51It's the new reality being coded into existence, one algorithm at a time.
03:55What are your thoughts on AI in medicine?
03:57Are you excited or do you have concerns?
04:00Let me know in the comments below.
04:01And for more on how technology is changing our world,
04:04don't forget to like and subscribe.
Comments